Skip to content

CRYO-CELL INTERNATIONAL, INC.: 10-K filed 2019-02-28

What CRYO-CELL INTERNATIONAL, INC. reported in its annual report filed 2019-02-28 (fiscal FY 2018): 49 published measures, 99 facts as tagged in accession 0001193125-19-057945.

This filing

Form
10-K (annual report)
Filed
2019-02-28
Fiscal period
fiscal FY 2018
Accession
0001193125-19-057945 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CRYO-CELL INTERNATIONAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-11-3042,390,143USD
At 2017-11-3023,909,997USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-11-3051,298,441USD
At 2017-11-3036,412,893USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-11-30-8,908,298USD
At 2017-11-30-12,502,896USD
At 2016-11-30-15,414,258USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-11-306,040,033USD
At 2017-11-306,279,154USD
At 2016-11-303,499,881USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-854,824USD365
2016-12-01 to 2017-11-302,315,100USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-12-01 to 2018-11-305,333,330USD365
2016-12-01 to 2017-11-305,718,173USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-12-01 to 2018-11-30446,163USD365
2016-12-01 to 2017-11-3098,333USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-12-01 to 2018-11-305,709,960USD365
2016-12-01 to 2017-11-30-3,031,925USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-11,282,411USD365
2016-12-01 to 2017-11-3093,025USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-11-30-25,329,515USD
At 2017-11-30-24,474,691USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-12-01 to 2018-11-307,463,051shares365
2016-12-01 to 2017-11-307,062,870shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-12-01 to 2018-11-307,463,051shares365
2016-12-01 to 2017-11-307,652,984shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-0.11USD/shares365
2016-12-01 to 2017-11-300.33USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-0.11USD/shares365
2016-12-01 to 2017-11-300.3USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-12-01 to 2018-11-304,472,504USD365
2016-12-01 to 2017-11-301,308,603USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-11-301,493,401USD
At 2017-11-30882,382USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-12-01 to 2018-11-30478,378USD365
2016-12-01 to 2017-11-30971,730USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-12-01 to 2018-11-305,189,303USD365
2016-12-01 to 2017-11-305,006,226USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-11-3029,535,210USD
At 2017-11-3012,736,921USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-12-01 to 2018-11-301,546,900USD365
2016-12-01 to 2017-11-301,302,650USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-11-3015,429,725USD
At 2017-11-3013,939,846USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-11-301,261,653USD
At 2017-11-301,928,542USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2018-11-301,941,411USD
At 2017-11-300USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2018-11-301,341,336USD
At 2017-11-30226,418USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-11-305,867,335USD
At 2017-11-305,125,591USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2016-12-01 to 2017-11-30446,621USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2018-11-3016,035,873USD
At 2017-11-30314,566USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-12-01 to 2018-11-3015,632,696USD365
2016-12-01 to 2017-11-3013,480,883USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-12-01 to 2018-11-3091,845USD365
2016-12-01 to 2017-11-3041,165USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-11-307,800,833shares
At 2017-11-307,103,941shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2018-11-30340,984USD
At 2017-11-3040,865USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2018-11-3012,943,510USD
At 2017-11-307,295,183USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-11-308,300,883USD
At 2017-11-307,449,228USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-11-306,807,482USD
At 2017-11-306,566,846USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2018-11-301,341,336USD
At 2017-11-30226,418USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-11-3011,361,532USD
At 2017-11-3010,290,694USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-11-3035,868,716USD
At 2017-11-3022,473,047USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-11-302,702,788USD
At 2017-11-302,582,475USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-854,824USD365
2016-12-01 to 2017-11-302,315,100USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-554,705USD365
2016-12-01 to 2017-11-302,321,557USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-12-01 to 2018-11-30241,000USD365
2016-12-01 to 2017-11-30230,000USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-12-01 to 2018-11-3076,000USD365
2016-12-01 to 2017-11-3035,000USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-24,723USD365
2016-12-01 to 2017-11-30-79,873USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-1,571,623USD365
2016-12-01 to 2017-11-30-1,382,523USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2017-12-01 to 2018-11-302,197,000USD365
2016-12-01 to 2017-11-302,074,000USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2017-12-01 to 2018-11-302,275,000USD365
2016-12-01 to 2017-11-30-765,000USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-12-01 to 2018-11-301,347,773USD365
2016-12-01 to 2017-11-301,149,875USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-316,650USD365
2016-12-01 to 2017-11-30-46,576USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-12-01 to 2018-11-30-666,889USD365
2016-12-01 to 2017-11-30443,112USD365

Inspect the source

Entity
CRYO-CELL INTERNATIONAL, INC. / CIK 0000862692
Captured
2026-09-20T04:59:44.726Z
SEC response SHA-256
db6274ac13e8b9460d5d6692afefc40788c565b8fd343e40b722f12a7b8f95ac

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000862692.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))